|
1
|
Maeda T, Hobbs RM, Merghoub T, et al: Role
of the proto-oncogene Pokemon in cellular transformation and ARF
repression. Nature. 433:278–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morrison DJ, Pendergrast PS, Stavropoulos
P, Colmenares SU, Kobayashi R and Hernandez N: FBI-1, a factor that
binds to the HIV-1 inducer of short transcripts (IST), is a POZ
domain protein. Nucleic Acids Res. 27:1251–1262. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davies JM, Hawe N, Kabarowski J, et al:
Novel BTB/POZ domain zinc-finger protein, LRF, is a potential
target of the LAZ-3/BCL-6 oncogene. Oncogene. 18:365–375. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kukita A, Kukita T, Ouchida M, Maeda H,
Yatsuki H and Kohashi O: Osteoclast-derived zinc finger (OCZF)
protein with POZ domain, a possible transcriptional repressor, is
involved in osteoclastogenesis. Blood. 94:1987–1997.
1999.PubMed/NCBI
|
|
5
|
Pessler F, Pendergrast PS and Hernandez N:
Purification and characterization of FBI-1, a cellular factor that
binds to the human immunodeficiency virus type 1 inducer of short
transcripts. Mol Cell Biol. 17:3786–3798. 1997.PubMed/NCBI
|
|
6
|
Apostolopoulou K, Pateras IS, Evangelou K,
et al: Gene amplification is a relatively frequent event leading to
ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J
Pathol. 213:294–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Merghoub T, Cattoretti G, Piazza F, et al:
Pokemon is required for cellular differentiation in multiple
tissues. Blood. 98:792a2001.
|
|
8
|
Maeda T, Hobbs R, Merghoub T, et al:
POKEMON is a proto-oncogene which plays a key role in
lymphomagenesis. Blood. 104:951a2004.
|
|
9
|
Laudes M, Bilkovski R, Oberhauser F, et
al: Transcription factor FBI-1 acts as a dual regulator in
adipogenesis by coordinated regulation of cyclin-A and E2F-4. J Mol
Med (Berlin). 86:597–608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG
and Hur MW: Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses
transcription of the tumor suppressor Rb gene via binding
competition with Sp1 and recruitment of co-repressors. J Biol Chem.
283:33199–33210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi WI, Jeon BN, Yun CO, et al:
Proto-oncogene FBI-1 represses transcription of p21CIP1 by
inhibition of transcription activation by p53 and Sp1. J Biol Chem.
284:12633–12644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roh HE, Lee MN, Jeon BN, et al: Regulation
of Pokemon 1 activity by sumoylation. Cell Physiol Biochem.
20:167–180. 2007.PubMed/NCBI
|
|
13
|
Samson SL and Wong NC: Role of Sp1 in
insulin regulation of gene expression. J Mol Endocrinol.
29:265–279. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zu X, Yu L, Sun Q, et al: SP1 enhances
Zbtb7A gene expression via direct binding to GC box in HePG2 cells.
BMC Res Notes. 2:1752009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calera MR and Pilch PF: Induction of Akt-2
correlates with differentiation in Sol8 muscle cells. Biochem
Biophys Res Commun. 251:835–841. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roche S, Downward J, Raynal P and
Courtneidge SA: A function for phosphatidylinositol 3-kinase beta
(p85alpha-p110beta) in fibroblasts during mitogenesis: requirement
for insulin- and lysophosphatidic acid-mediated signal
transduction. Mol Cell Biol. 18:7119–7129. 1998.
|
|
17
|
Rother KI, Imai Y, Caruso M, Beguinot F,
Formisano P and Accili D: Evidence that IRS-2 phosphorylation is
required for insulin action in hepatocytes. J Biol Chem.
273:17491–17497. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Slieker LJ, Sloop KW and Surface PL:
Differentiation method-dependent expression of leptin in adipocyte
cell lines. Biochem Biophys Res Commun. 251:225–229. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rosen OM: After insulin binds. Science.
237:1452–1458. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O’Brien RM and Granner DK: Regulation of
gene expression by insulin. Physiol Rev. 76:1109–1161. 1996.
|
|
21
|
Koontz JW and Iwahashi M: Insulin as a
potent, specific growth factor in a rat hepatoma cell line.
Science. 211:947–949. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Block GD, Locker J, Bowen WC, et al:
Population expansion, clonal growth, and specific differentiation
patterns in primary cultures of hepatocytes induced by HGF/SF, EGF
and TGF alpha in a chemically defined (HGM) medium. J Cell Biol.
132:1133–1149. 1996. View Article : Google Scholar
|
|
23
|
Scassa ME, Guberman AS, Varone CL and
Cánepa ET: Phosphatidylinositol 3-kinase and Ras/mitogen-activated
protein kinase signaling pathways are required for the regulation
of 5-aminolevulinate synthase gene expression by insulin. Exp Cell
Res. 271:201–213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saltiel AR and Pessin JE: Insulin
signaling pathways in time and space. Trends Cell Biol. 12:65–71.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boyd DB: Insulin and cancer. Integr Cancer
Ther. 2:315–329. 2003. View Article : Google Scholar
|
|
26
|
Thompson AD III and Kakar SS: Insulin and
IGF-1 regulate the expression of the pituitary tumor transforming
gene (PTTG) in breast tumor cells. FEBS Lett. 579:3195–3200. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Messina JL: Inhibition and stimulation of
c-myc gene transcription by insulin in rat hepatoma cells. Insulin
alters the intragenic pausing of c-myc transcription. J Biol Chem.
266:17995–18001. 1991.PubMed/NCBI
|
|
28
|
Saltiel AR and Kahn CR: Insulin signalling
and the regulation of glucose and lipid metabolism. Nature.
414:799–806. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun J and Jin T: Both Wnt and mTOR
signaling pathways are involved in insulin-stimulated
proto-oncogene expression in intestinal cells. Cell Signal.
20:219–229. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao ZH, Wang SF, Yu L, et al:
Overexpression of Pokemon in non-small cell lung cancer and
foreshowing tumor biological behavior as well as clinical results.
Lung Cancer. 62:113–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flegal KM, Carroll MD, Kuczmarski RJ and
Johnson CL: Overweight and obesity in the United States: prevalence
and trends, 1960–1994. Int J Obes Relat Metab Disord. 22:39–47.
1998.
|
|
32
|
Mason AL, Lau JY, Hoang N, et al:
Association of diabetes mellitus and chronic hepatitis C virus
infection. Hepatology. 29:328–333. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Michalopoulos GK and DeFrances MC: Liver
regeneration. Science. 276:60–66. 1997. View Article : Google Scholar
|
|
34
|
Motoo Y, Kobayashi K and Hattori N: Effect
of insulin on the growth of a human hepatoma cell line PLC/PRF/5: a
possible role of insulin receptor. Tohoku J Exp Med. 156:351–357.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Spydevold O, Sørensen H, Clausen OP and
Gautvik KM: Dexamethasone inhibition of rat hepatoma cell growth
and cell cycle traverse is reversed by insulin. Biochim Biophys
Acta. 1052:221–228. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Au WS, Kung HF and Lin MC: Regulation of
microsomal triglyceride transfer protein gene by insulin in HepG2
cells: roles of MAPKerk and MAPKp38. Diabetes. 52:1073–1080. 2003.
View Article : Google Scholar : PubMed/NCBI
|
